Practice guideline: Treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder
Top Cited Papers
- 12 February 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 94 (9), 392-404
- https://doi.org/10.1212/wnl.0000000000009033
Abstract
Objective To review pharmacologic and nonpharmacologic strategies for treating sleep disturbances in children and adolescents with autism spectrum disorder (ASD) and to develop recommendations for addressing sleep disturbance in this population. Methods The guideline panel followed the American Academy of Neurology 2011 guideline development process, as amended. The systematic review included studies through December 2017. Recommendations were based on evidence, related evidence, principles of care, and inferences. Major recommendations (Level B) For children and adolescents with ASD and sleep disturbance, clinicians should assess for medications and coexisting conditions that could contribute to the sleep disturbance and should address identified issues. Clinicians should counsel parents regarding strategies for improved sleep habits with behavioral strategies as a first-line treatment approach for sleep disturbance either alone or in combination with pharmacologic or nutraceutical approaches. Clinicians should offer melatonin if behavioral strategies have not been helpful and contributing coexisting conditions and use of concomitant medications have been addressed, starting with a low dose. Clinicians should recommend using pharmaceutical-grade melatonin if available. Clinicians should counsel children, adolescents, and parents regarding potential adverse effects of melatonin use and the lack of long-term safety data. Clinicians should counsel that there is currently no evidence to support the routine use of weighted blankets or specialized mattress technology for improving disrupted sleep. If asked about weighted blankets, clinicians should counsel that the trial reported no serious adverse events with blanket use and that blankets could be a reasonable nonpharmacologic approach for some individuals.Keywords
This publication has 49 references indexed in Scilit:
- Behavioral parent training to address sleep disturbances in young children with autism spectrum disorder: a pilot trialSleep Medicine, 2013
- Controlled‐release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo‐controlled trialJournal of Sleep Research, 2012
- Evaluation of sleep, puberty and mental health in children with long-term melatonin treatment for chronic idiopathic childhood sleep onset insomniaPsychopharmacology, 2011
- Policies and Practices Used by States to Serve Children With Autism Spectrum DisordersJournal of Disability Policy Studies, 2011
- Cognitive–behavioral therapy and hypnotic relaxation to treat sleep problems in an adolescent with diabetesJournal of Clinical Psychology, 2010
- Dose finding of melatonin for chronic idiopathic childhood sleep onset insomnia: an RCTPsychopharmacology, 2010
- Inadequate Sleep and Unintentional Injuries in Young ChildrenPublic Health Nursing, 2008
- Nocturnal Awakenings and Pediatric Injury RiskJournal of Pediatric Psychology, 2007
- Adolescents, substance abuse, and the treatment of insomnia and daytime sleepinessClinical Psychology Review, 2005
- Sleep problems in autism: prevalence, cause, and interventionDevelopmental Medicine and Child Neurology, 1999